Plain-English translation of NCT07191353 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a medication that may help your body build bone, can strengthen bones and muscles in women over 60. Researchers will compare the medication alone, strength training alone, both together, and a placebo (inactive pill) to see which approach works best. You'll have regular visits over several months where doctors will check your bone and muscle health through scans, blood tests, and physical assessments.
As women age after menopause, bones naturally become thinner and weaker, increasing the risk of fractures. Doctors want to find new ways to prevent this bone loss, and this medication might help by encouraging your body to build bone naturally, especially when combined with exercise.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of four groups: the medication alone, strength training alone, both together, or placebo with strength training. If you're assigned to strength training, you'll do resistance exercises for 1 hour, three times per week. Over 12–16 weeks, you'll have 5–7 visits to the hospital where you'll have blood drawn, bone and muscle scans, muscle biopsies (small tissue samples), and tests of your muscle strength and bone health. You'll also answer questions about your quality of life.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Denmark